NCT04176224View on ClinicalTrials.gov

Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

September 4, 2019

Study Completion Date

September 4, 2019

Conditions
Japanese Patients With ALS
Interventions
DRUG

MT-1186

Suspension

Trial Locations (1)

Unknown

Investigational site, Tokyo

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY